Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 14/20 | 0.45 |
| ▸ | MEN1 | O00255 | 9/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.45 |
| ▸ | LMNA | P02545 | 8/20 | 0.45 |
| ▸ | HTT | P42858 | 8/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | THRB | P10828 | 4/20 | 0.45 |
| ▸ | RECQL | P46063 | 4/20 | 0.45 |
| ▸ | POLB | P06746 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | XBP1 | P17861 | 1/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7604087 | 1.00 | MAPT (0.45) | MAPTMEN1KMT2ALMNAHTT | |
| SCHEMBL22489411 | 1.00 | MAPT (0.45) | MAPTMEN1KMT2ALMNAHTT | |
| SCHEMBL3131736 | 1.00 | MAPT (0.45) | MAPTMEN1KMT2ALMNAHTT | |
| SCHEMBL13928996 | 1.00 | MAPT (0.45) | MAPTMEN1KMT2ALMNAHTT | |
| Iodide SCHEMBL23668383 | 0.99 | MAPT (0.45) | MAPTMEN1KMT2ALMNAHTT | |
| Iodide SCHEMBL1156818 | 0.99 | MAPT (0.45) | MAPTMEN1KMT2ALMNAHTT | |
| Hydrochloric Acid SCHEMBL3020867 | 0.99 | MAPT (0.45) | MAPTMEN1KMT2ALMNAHTT | |
| Hydrochloric Acid SCHEMBL31402545 | 0.99 | MAPT (0.45) | MAPTMEN1KMT2ALMNAHTT | |
| Hydrochloric Acid SCHEMBL224253 | 0.99 | MAPT (0.45) | MAPTMEN1KMT2ALMNAHTT | |
| Iodide SCHEMBL1156819 | 0.99 | MAPT (0.45) | MAPTMEN1KMT2ALMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 750 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080936-A | Activated near-infrared two-region afterglow luminescence composite nano system and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122037607-A | Thiophenol-heptamethine cyanine dye derivative, self-assembled nanoparticle thereof, preparation method and application | 温州医科大学附属第二医院（温州医科大学附属育英儿童医院） | 2026-05-15 | — | — | CN | claimed |
| US-20260110689-A1 | METHODS AND COMPOSITIONS RELATED TO MODIFIED FLUOROPHORES | UNIV TEXAS (US) | 2026-04-23 | — | — | US | claimed |
| US-20260091143-A1 | NEAR-INFRARED IMAGING AGENT AND USES THEREOF | UNIV CASE WESTERN RESERVE (US) | 2026-04-02 | — | — | US | claimed |
| US-20260015618-A1 | Therapeutic Compounds for Red Blood Cell-Mediated Delivery of an Active Pharmaceutical Ingredient to a Target Cell | K2B THERAPEUTICS INC (US) | 2026-01-15 | — | — | US | claimed |
| US-20260007777-A1 | HEPTAMETHINE CYANINE NEAR-INFRARED FLUORESCENT DYE, PREPARATION METHOD THEREFOR AND USE THEREOF | NANJING NUOYUAN MEDICAL DEVICES CO LTD (CN) | 2026-01-08 | — | — | US | claimed |
| US-20250387521-A1 | THERANOSTIC FOR TREATING CANCER | UNIV CASE WESTERN RESERVE (US) | 2025-12-25 | — | — | US | claimed |
| US-20250360218-A1 | MITOCHONDRIA-TARGETING CANCER THERAPEUTIC COMPOSITION | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2025-11-27 | — | — | US | claimed |
| US-12466814-B2 | Sterically shielded heptamethine cyanine dyes | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2025-11-11 | — | — | US | claimed |
| US-20250293202-A1 | RESIN COMPOSITION AND METHOD OF FORMING A SEMICONDUCTOR PACKAGE WITH UNDERFILL USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-09-18 | — | — | US | claimed |
| CN-110642839-B | Nano probe and preparation method and application thereof | 深圳大学 | 2022-04-01 | — | — | CN | claimed |
| CN-110448699-B | Tumor cell nucleus targeted drug-loaded nanoparticle containing functional polypeptide modified heptamethine cyanine dyes and preparation method thereof | 天津医科大学 | 2022-03-11 | — | — | CN | claimed |
| EP-3664892-A2 | TUNABLE LUMINESCENT ORGANIC SALTS FOR ENHANCED IMAGING AND PHOTODYNAMIC THERAPY | Board of Trustees of Michigan State University (US) | 2020-06-17 | — | — | EP | claimed |
| WO-2019032683-A2 | TUNABLE LUMINESCENT ORGANIC SALTS FOR ENHANCED IMAGING AND PHOTODYNAMIC THERAPY | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2019-02-14 | — | — | WO | claimed |
| EP-3289615-A1 | ORGANIC SALTS FOR HIGH VOLTAGE ORGANIC AND TRANSPARENT SOLAR CELLS | Board of Trustees of Michigan State University (US) | 2018-03-07 | — | — | EP | claimed |
| WO-2016176008-A1 | ORGANIC SALTS FOR HIGH VOLTAGE ORGANIC AND TRANSPARENT SOLAR CELLS | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2016-11-03 | — | — | WO | claimed |
| EP-1012604-B1 | AGGLUTRIMETRIC ASSAYS IN BLOOD | ACCUMETRICS INC (US) | 2009-12-16 | — | — | EP | claimed |
| EP-1249343-B1 | Thermal initiator system using leuco dyes and polyhalogene compounds | KODAK GRAPHIC COMM GMBH (DE) | 2008-07-23 | — | — | EP | claimed |
| EP-1478516-B1 | IR-SENSITIVE COMPOSITION AND ON-PRESS DEVELOPABLE IR-SENSITIVE PRINTING PLATES | KODAK POLYCHROME GRAPHICS LLC (US) | 2006-04-12 | — | — | EP | claimed |
| EP-1079972-B1 | IR-SENSITIVE COMPOSITION AND USE THEREOF FOR THE PREPARATION OF PRINTING PLATE PRECURSORS | KODAK POLYCHROME GRAPHICS CO (US) | 2003-11-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015618-A1 | Therapeutic Compounds for Red Blood Cell-Mediated Delivery of an Active Pharmaceutical Ingredient to a Target Cell | CD47, MMAB, KDM4E | MAPT 2736/4885MEN1 259/4885KMT2A 573/4885 |
| US-12466814-B2 | Sterically shielded heptamethine cyanine dyes | FCGR3B, MYADM, FCGR2A | MAPT 1294/4885MEN1 76/4885KMT2A 3529/4885 |
| US-20250360218-A1 | MITOCHONDRIA-TARGETING CANCER THERAPEUTIC COMPOSITION | TSPO, TFAM, MCU | MAPT 2686/4885MEN1 2245/4885KMT2A 3004/4885 |
| US-20250387521-A1 | THERANOSTIC FOR TREATING CANCER | MKI67, BRCA1, FES | MAPT 2019/4885MEN1 100/4885KMT2A 2606/4885 |
| US-20260007777-A1 | HEPTAMETHINE CYANINE NEAR-INFRARED FLUORESCENT DYE, PREPARATION METHOD THEREFOR AND USE THEREOF | HCCS, PYGL, GOT1 | MAPT 4027/4885MEN1 77/4885KMT2A 2252/4885 |
| US-20260110689-A1 | METHODS AND COMPOSITIONS RELATED TO MODIFIED FLUOROPHORES | NONO, SIGMAR1, HTR3D | MAPT 1590/4885MEN1 3465/4885KMT2A 3329/4885 |
| US-20260091143-A1 | NEAR-INFRARED IMAGING AGENT AND USES THEREOF | IGSF11, VSIR, FCGR3B | MAPT 1122/4885MEN1 1377/4885KMT2A 3325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.